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Abstract
Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of insulin signaling and energy balance,
but its role in brown fat adipogenesis requires additional investigation.
Methodology/Principal Findings: To precisely determine the role of PTP1B in adipogenesis, we established preadipocyte
cell lines from wild type and PTP1B knockout (KO) mice. In addition, we reconstituted KO cells with wild type, substrate-
trapping (D/A) and sumoylation-resistant (K/R) PTP1B mutants, then characterized differentiation and signaling in these
cells. KO, D/A- and WT-reconstituted cells fully differentiated into mature adipocytes with KO and D/A cells exhibiting a
trend for enhanced differentiation. In contrast, K/R cells exhibited marked attenuation in differentiation and lipid
accumulation compared with WT cells. Expression of adipogenic markers PPARc, C/EBPa, C/EBPd, and PGC1a mirrored the
differentiation pattern. In addition, the differentiation deficit in K/R cells could be reversed completely by the PPARc
activator troglitazone. PTP1B deficiency enhanced insulin receptor (IR) and insulin receptor substrate 1 (IRS1) tyrosyl
phosphorylation, while K/R cells exhibited attenuated insulin-induced IR and IRS1 phosphorylation and glucose uptake
compared with WT cells. In addition, substrate-trapping studies revealed that IRS1 is a substrate for PTP1B in brown
adipocytes. Moreover, KO, D/A and K/R cells exhibited elevated AMPK and ACC phosphorylation compared with WT cells.
Conclusions: These data indicate that PTP1B is a modulator of brown fat adipogenesis and suggest that adipocyte
differentiation requires regulated expression of PTP1B.
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Introduction
The obesity epidemic has focused attention on adipose tissue
and adipocyte development (adipogenesis). Adipose tissue is an
important metabolic organ that integrates a wide array of
homeostatic processes and is crucial for whole-body insulin
sensitivity and energy metabolism [1]. White adipose tissue
(WAT) is the primary site for triglyceride storage and fatty acid
release in response to various energy requirements; whereas brown
adipose tissue (BAT) generates heat via mitochondrial uncoupling
of lipid oxidation [2]. Brown adipose is a key thermogenic tissue
with a well-established role in the defense against cold in a process
termed nonshivering thermogenesis [3]. In addition, BAT is
recognized for its anti-obesity properties with the increase in
brown adipose amount and/or function promoting a healthy
phenotype. Specifically, mice with higher amounts of BAT gain
less weight, are more insulin sensitive, and are protected from
diabetes [4,5,6,7]. Interest in the regulation and development of
BAT gained traction in recent years with the realization that adult
humans have distinct brown adipose tissue depots and that the
activity of BAT varies depending on adiposity, temperature,
gender and age [8,9,10,11].
Adipocyte differentiation is a complex process that requires
integration of a multitude of stimuli including nutrients and
hormones [12,13,14,15]. Despite differences in physiological
function and developmental origins of WAT and BAT, both
share similar canonical transcriptional cascades that control fat
differentiation [16]. Previous detailed studies of WAT differenti-
ation identified peroxisome proliferator-activated receptor gamma
(PPARc) and CCAAT/enhancer-binding proteins (C/EBPs) as
critical transcription factors regulating differentiation (reviewed in
[17]). PPARc is also necessary for brown fat cell development but
not sufficient to drive mesenchymal cells into a brown fat cell fate.
Recently, bone morphogenic protein 7 (BMP7) was identified as a
regulator of brown fat cell differentiation program [18]. In
addition, insulin and insulin-like growth factor 1 (IGF1) play
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preadipocytes derived from insulin receptor (IR) and insulin
receptor substrates 1–4 (IRSs) knockout (KO) mice highlight the
relevance of upstream components in insulin signaling in BAT
differentiation [20,21,22,23].
Tyrosyl phosphorylation is a major regulator of insulin signaling
and is tightly controlled by the opposing actions of protein-tyrosine
kinases (PTKs) and protein-tyrosine phosphatases (PTPs) [24,25].
Protein-tyrosine phosphatase 1B (PTP1B) is an abundant, widely
expressed non-receptor tyrosine-specific phosphatase that is
localized on the cytoplasmic face of the endoplasmic reticulum
(ER) [26,27,28]. Whole-body PTP1B deficient mice are hyper-
sensitive to insulin, lean and resistant to high fat diet-induced
obesity [29,30]. The leanness is caused by increased energy
expenditure that is mediated, at least in part, by neuronal PTP1B
since neuron-specific PTP1B KO mice exhibit reduced body
weight and increased energy expenditure [31]. In contrast, muscle-
and liver-specific PTP1B deletion leads to improved insulin
sensitivity without alterations in body weight [32,33]. However,
the role of PTP1B in adipose tissue, specifically BAT is less clearly
defined. Of note, whole-body PTP1B deficient mice exhibit
increased AMP-activated protein kinase (AMPK) activity and
mitochondrial content in BAT [34]. In addition, it was recently
reported that PTP1B deficiency has a beneficial effect on brown
adipocyte differentiation and protection against apoptosis [35].
In the current study we investigated the role of PTP1B in brown
adipocyte differentiation and signaling. We utilized preadipocytes
from WT and PTP1B-deficient mice and reconstituted cells to
reveal that PTP1B modulates brown fat adipogenesis. In addition,
we demonstrated a role for PTP1B in regulating insulin and
AMPK signaling in brown adipocytes.
Results
Generation and characterization of PTP1B-deficient and
reconstituted brown adipocytes
To investigate the role of PTP1B in brown adipocyte
differentiation, we generated immortalized brown preadipocytes
from wild type (Con) and whole-body PTP1B KO mice as
described in Methods. To determine whether alterations in KO
cells were directly caused by PTP1B deficiency, we generated
isogenic cells by reconstituting KO cells with human (h) PTP1B
(WT) as described in Methods. Of note, hPTP1B shares a high
degree of homology to mouse (m) PTP1B, and we have previously
demonstrated that hPTP1B can rescue the effects of mPTP1B
deletion in mouse embryonic fibroblasts in response to growth
factors stimulation [36]. In addition, KO cells were reconstituted
with substrate-trapping hPTP1B D181A (D/A) mutant that
retains substrate binding but is catalytically impaired [37], and
sumoylation-resistant mutant hPTP1B K73, 335, 347, 389R (K/
R) [38]. PTP1B is progressively sumoylated after insulin
stimulation leading to inhibition of its catalytic activity and
suppression of its ability to downregulate the IR [38]. Immunoblot
analysis of cell lysates revealed that hPTP1B was expressed in all
reconstituted cells (WT, D/A, and K/R) while mouse (m) PTP1B
was expressed in Con cells and absent in KO cells (Fig. 1A). Given
the cross reactivity of mouse and human PTP1B antibodies [39],
we estimated that hPTP1B expression in reconstituted cells was
roughly comparable to mPTP1B in wild type cells (Con).
Differentiation of KO and reconstituted cells into brown
adipocytes was performed as described in Methods and outlined
in Fig. 1B. Cells were stained using the fat-specific dye oil red O to
monitor lipid accumulation at various days of differentiation
(Fig. 1B, C). Differentiation was quantitated by extracting oil red
O from stained cells and determining absorbance (from 9
independent experiments) (Fig. 1D). WT cells accumulated fat
droplets and exhibited a fully differentiated phenotype with .90%
of the cells containing multilocular fat droplets at day 8 (Fig. 1C).
KO and D/A cells exhibited a trend for enhanced differentiation
compared with WT cells, but did not reach statistical significance
(Fig. 1C, D). In contrast, K/R cells treated with the same protocol
failed to differentiate with only a small percentage of cells able to
accumulate fat. Together, our findings indicate that differentiation
of brown adipocytes requires a regulated expression of PTP1B and
that its sumolyation-resistant mutant dramatically inhibits differ-
entiation.
Patterns of differentiation correlate with expression of
adipogenic markers
To further investigate the role of PTP1B in brown adipose
differentiation, we determined the expression of adipogenic
markers PPARc, C/EBPa, C/EBPd, PPARc coactivator 1a
(PGC1a) and preadipocyte factor 1 (Pref1) mRNAs in KO and
reconstituted cells during differentiation. Consistent with previous
reports [23,40], PPARc exhibited a progressive increase in
expression during differentiation in WT cells (Fig. 2A). Notably,
KO and D/A cells revealed a comparable pattern of PPARc
expression, while K/R cells exhibited blunted expression through-
out differentiation. Similarly, C/EBPa exhibited comparable
expression pattern to that of PPARc. Transcripts of C/EBPa
peaked on day 4–6 in WT, KO and D/A cells, while K/R cells
exhibited blunted expression (Fig. 2B). In addition, PGC1a
mRNA expression pattern was comparable to that of PPARc
increasing progressively during differentiation in WT, KO and D/
A cells while K/R cells exhibited blunted expression (Fig. 2C). C/
EBPd levels were generally low in all cells and no apparent trend
was observed (Fig. 2D). On the other hand, expression of Pref1, an
inhibitor of adipocyte differentiation (reviewed in [41]), was
elevated in K/R cells compared with KO, WT and D/A cells
(Fig. 2E). Finally, protein expression of uncoupling protein 1
(UCP1), a marker of brown adipocyte differentiation, was elevated
in differentiated KO and D/A cells compared with WT and was
not detectable in K/R cells. This is in line with in vivo studies that
report increased UCP1 expression (by immuno-blotting and
immuno-histochemistry) in BAT of PTP1B KO mice compared
with wild type mice [34]. Therefore, K/R cells exhibited
attenuated differentiation, as indicated by lipid accumulation,
mRNA and protein expression.
Tyrosyl phosphorylation and differentiation of PTP1B-
deficient and reconstituted adipocytes
Overall tyrosyl phosphorylation inversely correlates with
adipocyte differentiation [23]; we reasoned that PTP1B deletion
and/or reconstitution will likely alter tyrosyl phosphorylation and
modulate differentiation. Overall tyrosyl phosphorylation was
determined in lysates of KO and reconstituted adipocytes at
various stages of differentiation (Fig. 3A). As differentiation
progressed, we detected a trend for mild decrease in tyrosyl
phosphorylation; however the overall pattern and levels were
comparable in KO, WT and K/R cells (Fig. 3A). In line with this,
we observed a trend of increased PTP1B expression in WT cells
during differentiation, but it did not reach statistical significance
(data not shown). Please note that enhanced tyrosyl phosphory-
lation in D/A cells likely reflects ‘‘trapped’’ PTP1B substrates that
are protected against dephosphorylation. Previous studies indicate
that Erk phosphorylation decreases during the progression of
differentiation [22,23]. Indeed, Erk phosphorylation declined in
PTP1B and Brown Fat Differentiation
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failed to attenuate Erk phoshorylation (Fig. 3B). Finally, PI3K and
its downstream effector, Akt play an important role in brown
adipocyte differentiation [20]. Akt (Ser473) phopshorylation,
adjusted to Akt expression, increased as differentiation proceeded
in all cells (Fig. 3C). In addition, Akt phosphorylation was higher
in KO, D/A and K/R cells compared with WT at day 0, but these
differences were not sustained at later stages of differentiation
(Fig. 3C). Thus, while some differences in Erk and Akt
phosphorylation were observed between cells during differentia-
tion, these are unlikely to account, on their own, for the altered
differentiation pattern in these cells.
Regulation of insulin signaling in brown adipocytes by
PTP1B
Insulin signaling is an important regulator of brown fat
adipogenesis with upstream components, IR [22] and IRS1/3
[20,23,42] playing crucial roles. PTP1B attenuates insulin signaling
bydephosphorylatingIR[43,44]andpossiblyIRS1[45,46].Initially,
we determined alterations in insulin signaling in differentiated brown
adipocytes derived from wild type (Con) and KO mice. Cells were
starved overnight then stimulated with insulin for 5 minutes and
tyrosyl phosphorylation of IR and IRS1 was determined in
immunoprecipitates. Insulin-stimulated tyrosyl phosphorylation of
IR and IRS1 was significantly enhanced in KO cells compared with
controls (Fig. 4A, B). Enhanced insulin-induced IRS1 tyrosyl
phosphorylation in KO cells could be primary indicating that
IRS1 is a substrate of PTP1B, or secondary due to increased IR
phosphorylation in KO cells. To determine if PTP1B directly
interactswithIRS1indifferentiatedbrownadipocytes,weperformed
substrate-trapping experiments as previously described [37].
hPTP1B was immunoprecipitated (using FG6 antibodies) from
lysates of WT and D/A cells then blotted using anti-phosphotyrosine
antibodies (Fig. 4C). Notably, a hyper-phosphorylated band, whose
size corresponds to IRS1 was detected in PTP1B immunoprecipi-
tates of insulin-stimulated D/A cells. Indeed, reprobing with IRS1
antibodies identified the protein as IRS1 demonstrating that it is a
direct target of PTP1B in brown adipocytes.
Next, we evaluated alterations in insulin signaling in isogenic
KO and reconstituted differentiated adipocytes. Insulin-stimulated
Figure 1. PTP1B regulates brown adipocyte differentiation. A) Immunoblots of human (h) and mouse (m) PTP1B expression in immortalized
brown adipocytes from wild type mice (Con), PTP1B knockout (KO) mice, and KO cells reconstituted with hPTP1B (WT), substrate-trapping (D/A), and
sumoylation-resistant (K/R) hPTP1B mutants. Blots were probed with anti-Tubulin antibodies as a control for loading. B) Schematic depicting timeline
of cell differentiation and oil red O staining. C) Brown adipose precursor cells were grown to confluence, then differentiation was induced as
described in Methods. At various stages of differentiation, cells were fixed and stained with oil red O, then the dye was extracted and its absorbance
(520 nm) quantitated (D). Graph represents data from nine independent experiments, and data are expressed as mean 6 SEM. (**) indicates
significant difference between K/R and WT, KO and D/A cells.
doi:10.1371/journal.pone.0016446.g001
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elevated in KO and D/A cells compared with WT cells (Fig. 4D).
By contrast, IR phosphorylation was significantly decreased in K/
R cells consistent with the inability of insulin to suppress activity of
PTP1B K/R [38]. Similarly, insulin-stimulated IRS1 tyrosyl
phosphorylation, normalized to its expression, was elevated in
KO and D/A cells compared with WT cells, and K/R cells
exhibited comparable IRS1 phosphorylation to WT cells (Fig. 4E).
Downstream insulin signaling was assessed by determining basal
and insulin-stimulated Erk and Akt phosphorylation in differen-
tiated adipocytes. Erk phosphorylation was significantly induced
5 mins after insulin stimulation compared with basal, but no major
differences were observed between cells (Fig. 4F). Similarly, Akt
phosphorylation was significantly induced after insulin stimulation
compared with basal, but no major differences were observed
between cells (Fig. 4G). Together, our findings indicate that
PTP1B is a regulator of IR signaling and that IRS1 is a direct
PTP1B substrate in brown adipocytes.
Regulation of AMPK signaling in brown adipocytes by
PTP1B
AMPK is a fuel sensing enzyme complex and a regulator of
brown adipose differentiation [47]. BAT from whole-body PTP1B
KO mice exhibit increased a1 and a2 AMPK activation, as well as
increased phosphorylation of a1 subunit at Thr172 compared with
controls [34]. In line with these observations, phosphorylation of
AMPKa (Thr172), adjusted to AMPKa expression was elevated in
KO and D/A cells compared with controls (Fig. 5A). In addition,
K/R cells exhibited elevated AMPKa phosphorylation compared
with controls. AMPK activation leads to phosphorylation of its
downstream target acetyl-CoA carboxylase (ACC) at Ser79 and
ACC inhibition [48,49]. Consistent with AMPKa phosphoryla-
tion, ACC phosphorylation (Ser79) was elevated in KO, D/A and
K/R cells compared with controls (Fig. 5B). LKB1 is one of the
upstream kinases that activate AMPKa by phosphorylating
Thr172 [50,51]. LKB1 protein levels were elevated in KO, D/A
and K/R cells compared with controls (Fig. 5C) and likely to
contribute to increased AMPK phophorylation in these cells.
Insulin-stimulated glucose uptake is impaired in PTP1B K/
R adipocytes
Basal and insulin-stimulated 2-deoxy-glucose uptake was
determined in differentiated KO and reconstituted cells as
described in Methods. There was no significant difference in
basal glucose transport between cells, although KO cells exhibited
a trend for increased glucose uptake compared with WT, but that
did not reach statistical significance (Fig. 6A). After insulin
stimulation, WT cells exhibited a significant increase in glucose
uptake (,5 fold) in line with published observations [20,21]. A
comparable increase in insulin-stimulated glucose uptake was
observed in KO cells. In addition, insulin-induced glucose uptake
was significantly enhanced in D/A cells and attenuated in K/R
Figure 2. Expression of differentiation markers in PTP1B KO and reconstituted adipocytes. mRNA expression of PPARc (A), C/EBPa (B),
PGC1a (C), C/EBPd (D) and Pref1 (E) at different days of differentiation, measured by quantitative real-time PCR and normalized against GAPDH.
Results are representative of two independent experiments and data are expressed as mean 6 SEM. (F) Immunoblots of UCP1 expression in
differentiated cells. Blots were probed for hPTP1B and with anti-Tubulin antibodies as a control for loading.
doi:10.1371/journal.pone.0016446.g002
PTP1B and Brown Fat Differentiation
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16446cells compared with WT (Fig. 6A). Decreased insulin-induced
glucose uptake in K/R cells was paralleled by attenuated Glut4
expression in these cells (Fig. 6B). On the other hand, elevated
glucose uptake in D/A cells was not mirrored by comparable
increase in Glut4 expression in total lysates. This suggests that
other factor(s), including but not limited to Glut4 translocation,
could be altered in these cells. At any rate, our findings
demonstrated impaired insulin-stimulated glucose uptake in K/
R brown adipocytes.
Troglitazone treatment increases differentiation capacity
of K/R cells
K/R cells failed to accumulate the adipogenic marker PPARc
and given its role in brown and white adipose differentiation [17],
we determined the effects of PPARc activation on the differen-
tiation capacity of K/R cells. WT and K/R cells were treated with
the PPARc agonist troglitazone and differentiation was monitored.
Addition of troglitazone to WT cells did not significantly alter their
differentiation profile probably due to the natural differentiation
potential of these cells (Fig. 7A, B). On the other hand, PPARc
activation significantly improved the ability of K/R cells to
differentiate as measured by oil red O staining (Fig. 7A, B). Thus,
troglitazone treatment is sufficient to override the differentiation
deficit in K/R cells.
Discussion
Adipocyte differentiation requires integration of a multitude of
stimuli and coordinated regulation of cellular responses
[12,13,14,15]. Despite recent confluence of discoveries on brown
fat adipogenesis, molecular regulators of this complex mechanism
are not fully identified. PTP1B is an established physiological
regulator of systemic insulin sensitivity and energy balance, but its
role in brown fat adipogenesis warrants additional investigation. In
this study we utilized immortalized brown preadipocytes from wild
type and PTP1B KO mice and reconstituted KO preadipocytes to
address the role of PTP1B in adipogenesis. These cells provide a
useful platform since preadipocytes can differentiate into mature
brown adipocytes with accumulation of multilocular fat droplets
and expression of adipogenic and differentiation markers [22,42].
In addition, these cells are an established model for dissecting the
Figure 3. Overall tyrosyl phosphorylation, Erk and Akt phosphorylation during differentiation. A) Overall tyrosyl phosphorylation in WT,
KO, D/A and K/R cells during differentiation. Total lysates were prepared from cells on days 0, 4 and 8 of differentiation. Blots were probed using anti-
phosphotyrosine and anti-hPTP1B antibodies. Molecular weight markers are indicated on the right of the blot. Total lysates from cells at days 0, 4 and
8 of differentiation were immunoblotted for p-Erk (B) and p-Akt (C) and the corresponding proteins. (*) indicates statistically significant difference
between KO, D/A or K/R and WT under the same treatment condition, while (
#) indicates statistically significant difference between WT, KO, D/A or K/
R and their corresponding basal (day 0).
doi:10.1371/journal.pone.0016446.g003
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adipogenesis and glucose uptake [20,23,42]. Moreover, PTP1B-
reconstituted cells help identify if observed alterations in KO cells
are directly caused by PTP1B deletion.
Using standard differentiation protocols, KO and D/A
preadipocytes exhibited a trend (that did not reach statistical
significance) for increased differentiation and accumulation of fat
droplets compared with WT cells. These findings are in line with
those of Miranda et al. who report beneficial effects of PTP1B
deficiency on brown fat adipogenesis [35]. Conversely, differen-
tiation of preadipocytes expressing a sumoylation-resistant PTP1B
mutant (K/R) was dramatically reduced compared with controls.
The underlying reason(s) for attenuated K/R preadipocyte
differentiation is not clear. One scenario involves attenuated
insulin signaling in these cells (see next paragraph). Another
possibility involves alteration of signaling in distinct cellular
compartment(s). The bulk of sumoylated PTP1B localizes to the
perinuclear region [38], and since K/R is resistant to insulin-
induced downregulation, then presumably K/R cells manifest
increased and/or prolonged PTP1B activation at this region.
Therefore, K/R could modulate insulin (and potentially other)
signaling amplitude and/or duration to attenuate differentiation.
In addition, we cannot rule out that K/R regulates a distinct set of
cellular substrate(s), and this warrants additional investigation. At
any rate, treatment of K/R cells with the PPARc agonist
troglitazone fully recovers the differentiation blockade in these
Figure 4. Altered insulin signaling in PTP1B KO and reconstituted adipocytes. Brown adipocyte cell lines from WT (Con) and PTP1B KO (KO)
mice were differentiated then serum starved O/N and stimulated with insulin (100 nM) for 5 minutes. A) Lysates were immunoprecipitated using IR
antibodies, immunoblotted with anti-phosphotyrosine antibodies, and then stripped and reprobed for IR to control for loading. B) IRS1 was
immunoprecipitated from adipocyte lysates, immunoblotted with anti-phosphotyrosine antibodies, and then stripped and reprobed for IRS1 to
control for loading. C) Lysates from cells reconstituted with WT and D/A were immunoprecipitated using hPTP1B antibodies (FG6) followed by
immunoblotting with anti-phosphotyrosine and anti-IRS1 antibodies. (D–G) Isogenic KO and reconstituted differentiated cells were serum starved O/
N then stimulated with insulin for 5 or 10 minutes. D) Lysates were immunoprecipitated using IR antibodies, immunoblotted with anti-
phosphotyrosine antibodies, and then stripped and reprobed for IR to control for loading. E) IRS1 was immunoprecipitated from adipocyte lysates,
immunoblotted with anti-phosphotyrosine antibodies, and then stripped and reprobed for IRS1 to control for loading. Cell lysates were
immunoblotted for p-Erk (F) p-Akt (G) and the corresponding total proteins. Bar graphs are data from three independent experiments and are
presented as means 6 SEM. (*) indicates statistically significant difference between KO, D/A or K/R and WT under the same treatment condition, while
(
#) indicates statistically significant difference between WT, KO, D/A or K/R and their corresponding basal (no insulin).
doi:10.1371/journal.pone.0016446.g004
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indirectly caused by the insulin-sensitizing effects of thiazolidine-
dione. Of note, troglitazone treatment of IR-deficient brown
preadipocytes slightly improves their differentiation profile [22],
and in IRS1-deficient preadipocytes reverses some of their
differentiation deficits (Glut4 expression) without affecting others
(fat accumulation) [20]. Although the exact mechanism of
impaired differentiation of K/R cells requires additional investi-
gation, our results demonstrate that PTP1B regulates brown fat
adipogenesis.
PTP1B can regulate brown fat adipogenesis through insulin-
dependent and insulin-independent signaling pathways (please see
schematic in Fig. 8). Numerous studies establish insulin signaling
as a critical regulator of brown fat adipogenesis [20,21,22,23,42].
Brown preadipocyte cell lines from IR KO mice exhibit
dramatically impaired differentiation [22]. Similarly, preadipo-
cytes from IRS1 KO mice exhibit a marked decrease in
differentiation and lipid accumulation [20,23,42]. In addition,
expression of adipogenic makers and transcription factors (such as
PPARc, C/EBPa, PGC1a, Glut4, and fatty acid synthase) is
attenuated in preadipocytes from IR and IRS1 KO mice
[20,22,23]. Our studies clearly established PTP1B as a regulator
of IR and IRS1 signaling in differentiated brown adipocytes and
demonstrated that IRS1 is a substrate of PTP1B in these cells.
Insulin-induced IR and IRS1 tyrosyl phosphorylation was elevated
in cells with abolished/minimal PTP1B activity (KO and D/A,
respectively) and attenuated in those with increased/prolonged
PTP1B activity (K/R). Similarly, PPARc, C/EBPa, and PGC1a
mRNA was increased in WT, K/O and D/A cells compared with
K/R. Notably, our studies demonstrated regulation of insulin-
stimulated glucose uptake in adipocytes by PTP1B, but that did
not fully correlate with alterations in IR and IRS1 tyrosyl
phosphorylation and Glut4 expression. This in line with previous
studies [52,53,54,55] that suggest that a multitude of factors are
required to evoke maximal insulin-stimulated glucose transport
including, but not limited to, modulation of signaling at specific
Figure 5. Altered AMPK signaling in PTP1B KO and reconstituted adipocytes. A) Immunoblotting of AMPKa subunit phosphorylation
(Thr172) in differentiated KO and reconstituted brown adipocytes under starved and insulin-stimulated conditions. Phosphorylation of ACC (Ser79)
(B), and LKB1 expression (C) in differentiated WT, KO, D/A and K/R cells at basal and insulin-stimulated conditions. Bar graphs are data from three
independent experiments and are presented as means 6 SEM. (*) indicates statistically significant difference between KO, D/A or K/R and WT under
the same treatment condition, while (
#) indicates statistically significant difference between WT, KO, D/A or K/R and their corresponding basal (no
insulin).
doi:10.1371/journal.pone.0016446.g005
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alteration of insulin signaling via modulation of PTP1B activity
accounts, at least in part, for the observed differentiation effects.
PTP1B also can regulate brown fat adipogenesis through
insulin-independent signaling pathways (Fig. 8). AMPK has been
implicated in the regulation of brown fat adipogenesis. Inhibition
Figure 6. Insulin-induced glucose uptake is impaired in K/R adipocytes. A) Differentiated KO and reconstituted cells were serum starved O/
N then stimulated with insulin (100 nM) for 30 minutes followed by addition of 2-deoxy-[
3H] glucose for 3 minutes. Data are expressed as nmol of
glucose taken up/mg of cell protein/min (left panel) and as percentage of basal uptake in WT cells (right panel). Bar graphs are data from three
independent experiments and data are presented as means 6 SEM. B) Immunoblots of Glut4 expression in differentiated cells. Blots were probed
with anti-Tubulin antibodies as a control for loading. (*) indicates statistically significant difference between basal and insulin-stimulated conditions in
each cell type, while (
#) indicates statistically significant difference between insulin-stimulated glucose uptake in KO, D/A and K/R cells compared
with WT.
doi:10.1371/journal.pone.0016446.g006
Figure 7. Differentiation capacity of K/R cells is improved by troglitazone treatment. WT and K/R cells were induced to differentiate in the
absence or presence of 25 mM troglitazone. A) At differentiation days 0 and 8 cells were stained with oil red O and differentiation quantitated (B).
Graph represents data from three independent experiments, and data are expressed as mean 6 SEM. (*) indicates statistically significant difference
between untreated K/R and WT cells, and (
#) indicates statistically significant difference between untreated K/R and troglitazone-treated K/R cells.
doi:10.1371/journal.pone.0016446.g007
PTP1B and Brown Fat Differentiation
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and chronic activation of AMPK in vivo increases brown
adipocytes within WAT depots [47]. Notably, AMPK activity is
elevated, and AMPK target genes that regulate mitochondrial
biogenesis are induced in BAT of PTP1B KO mice [34]. In line
with this, our data demonstrated regulation of AMPK signaling by
PTP1B in brown adipocytes. Collectively, these findings indicate
that PTP1B can regulate brown adipose differentiation, at least in
part, through AMPK signaling. Finally, we cannot rule out
modulation of additional affectors(s) of brown adipose differenti-
ation by PTP1B (Fig. 8). Adipogenic differentiation is associated
with downregulation of Wnt/b-catenin signaling [56,57,58]. Since
PTP1B has been implicated in regulating b-catenin signaling
[59,60] it is tempting to speculate that it could influence
adipogenesis through this signaling pathway. Proper execution of
adipogenesis requires integration of a wide array of stimuli and
regulated expression of numerous genes, so it is not surprising that
PTP1B participates in this complex process through regulating
various signaling pathways.
In summary, our studies identify PTP1B as a modulator of
brown fat adipogenesis, and suggest that adipocyte differentiation
requires regulated expression of PTP1B. These findings are of
direct relevance to obesity and diabetes given the contribution of
brown fat to energy homeostasis, and considering that PTP1B is a
target that is being harnessed as a potential therapeutic.
Materials and Methods
Chemicals and reagents
Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine
serum (FBS) and trypsin were purchased from Invitrogen
(Carlsbad, CA). Antibodies for human PTP1B (FG6), mouse
Figure 8. Proposed model of regulation of brown fat adipogenesis by PTP1B. PTP1B can regulate adipogenesis through insulin-dependent
and insulin-independent pathways. Activation of cell surface receptors of insulin or IGF1 leads to phosphorylation of IRS proteins, activation of PI3K
and MAPK pathway, and glucose uptake. Alterations in downstream signaling (summarized in Tseng et al. [23,40]) lead to the initiation of
transcriptional cascades that involve PPARc, C/EBPs, and PGC1a and cause changes that are required for differentiation of brown adipocytes
(expression of Glut4 and UCP1). PTP1B dephosphorylates IR and IRS1 in differentiated brown adipocytes and modulates insulin-stimulated glucose
uptake. In addition, PTP1B regulates LKB1/AMPK signaling pathway in differentiated brown adipocytes. Conceivably, PTP1B also could modulate
other affector(s) of cellular signaling to regulate transcription factors and cofactor to influence differentiation. Effects of KO, D/A and K/R on adipose
differentiation, IR and IRS1 tyrosyl phosphorylation, glucose uptake, and LKB1/AMPK signaling are summarized. Alterations in KO, D/A and K/R are
indicated with the symbol (+) and compared with WT (set at ++). Arrows indicate activation and T-shaped lines indicate repression. A dashed line
indicates that the connection has not been completely established.
doi:10.1371/journal.pone.0016446.g008
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(Lake Placid, NY), pAkt (Ser473), pErk, pAMPK (Thr172),
AMPK, pACC (Ser79), ACC were purchased from Cell Signaling
Technology (Beverly, MA), LKB1, Tubulin, Akt and Erk were
from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish
peroxidase (HRP)-conjugated secondary antibodies were pur-
chased from BioResources International (Carlsbad, CA). Unless
otherwise indicated, chemicals were purchased from Sigma (St.
Louis, MO).
Cell isolation and culture
Brown adipocytes and their precursor cells were isolated from
newborn wild type and whole-body PTP1B KO mice by
collagenase digestion as described previously [61]. Preadipocytes
were immortalized by infection with the retroviral vector pBABE
encoding SV40T-antigen then selected with puromycin (2 mg/
ml). To induce cell differentiation, preadipocytes were grown to
confluence in culture medium containing 20% FBS. Confluent
cells were then switched to differentiation media containing 20%
FBS, 20 nM insulin and 1 nM triiodothyronine [T3] for
48 hours. Adipocyte differentiation was induced by treating cells
for 48 h in differentiation medium further supplemented with
0.5 mM dexamethasone, 0.5 mM isobutylmethylxanthine, and
0.125 mM indomethacin (induction media). After induction,
cells were returned to differentiation medium, and at day 8
exhibited a fully differentiated phenotype with massive accumu-
lation of multilocular fat droplets. All animal work was
conducted following federal guidelines and in accordance with
University of California Davis IACUC approval (protocol #
13064).
For oil red O staining, cells were fixed with 10% buffered
formalin for at least 1 hour at room temperature. Cells were then
stained for one hour with filtered oil red O solution (5g/liter in
isopropyl alcohol), washed with distilled water, and visualized. Oil
red O was quantified spectrophotometrically at 520 nm.
PTP1B KO cell lines were reconstituted using retrovirus
encoding human PTP1B wild type (WT), substrate-trapping
mutant PTP1B D/A [37], and sumoylation-resistant mutant
PTP1B K/R [38] as we previously described [36]. Briefly, viral
W NX-packaging cells were transfected with retroviral vectors
using Lipofectamine 2000 (Invitrogen) following manufacturer’s
instructions and viral supernatants were harvested 48 h after
transfection. PTP1B KO cells were infected with polybrene
(4 mg/ml)-supplemented virus-containing supernatants. Selec-
tion was started 48 hours after infection with 200 mg/ml of
hygromycin (Invitrogen) and pools of drug-resistant cells
maintained.
Biochemical analyses
For signaling experiments, cells were starved overnight then
stimulated with insulin (100 nM) for 5 or 10 minutes. Cells were
lysed using radio-immunoprecipitation assay (RIPA) buffer
(10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% sodium dodecyl
sulfate [SDS], 1% Triton X-100, 1% sodium deoxycholate, 5 mM
EDTA, 1 mM NaF, 1 mM sodium orthovanadate and protease
inhibitors). Extracts were sonicated and clarified by centrifugation
at 13,000 rpm for 10 min, and protein concentrations were
determined using a bicinchoninic acid protein assay kit (Pierce
Chemical, Rockford, IL). Proteins (500–1000 mg) were subjected
to immunoprecipitation using IR, IRS1 and phosphotyrosine
(4G10) antibodies. For substrate-trapping experiments, lysates
were prepared in 1% NP40 buffer with a protease inhibitor
cocktail (without sodium orthovanadate) and hPTP1B was
immunoprecipitated using FG6 antibodies. Immune complexes
were collected on protein G-Sepharose beads (GE Healthcare) and
washed with lysis buffer. Proteins were resolved by SDS-PAGE
and transferred to PVDF membranes. Immunoblotting of total cell
lysates and immunoprecipitates was performed with antibodies for
phosphotyrosine (1/10,000), IR (1/1,000), IRS1 (1/500), pErk
(Thr202/Tyr204) (1/20,000), pAkt (Ser473) (1/10,000), Erk (1/
10,000), Akt (1/5,000), UCP1 (1/5,000), pAMPKa (1/2,000),
AMPKa (1/2,000), pACC (1/1,000), LKB1 (1/2,000) and
Tubulin (1/1,000). After incubation with appropriate secondary
antibodies, proteins were visualized using enhanced chemilumi-
nescence (Amersham Biosciences). Pixel intensities of immunore-
active bands were quantified using FluorChem 9900 (Alpha
Innotech).
RNA was extracted from differentiated adicpocytes using
TRIzol reagent (Invitrogen). cDNA was generated using high-
capacity cDNA Archive Kit (Applied Biosystems). Expression of
PPARc, C/EBPa, C/EBPd, PGC1a and Pref1 was assessed by
quantitative real-time PCR (iCycler, BioRad) with appropriate
primers (Table S1) and normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Glucose uptake assay
Cells were assayed for glucose uptake essentially as described
[62]. Briefly, differentiated brown adipocytes were treated with
insulin for 30 minutes after which 2-deoxy-[
3H] glucose (0.5 mCi/
ml, final concentration) was added for an additional 3 minutes.
The incorporated radioactivity was quantitated using liquid
scintillation counting.
Statistical analyses
Data are expressed as means 6 standard error of the mean
(SEM). Statistical analyses were performed using JMP program
(SAS Institute). Comparisons between groups were made by
unpaired two-tailed Student’s t test. Differences were considered
significant at P#0.05 and highly significant at P#0.01. A single
symbol (such as *) indicates P#0.05 and a double symbol (**)
indicates P#0.01.
Supporting Information
Table S1 Primers used for real time PCR. Primer
sequences used to determine mRNA expression levels of PPARc,




We thank Drs. Kohjiro Ueki (University of Tokyo) for help and advice on
brown adipocyte culture, Jonathan Chernoff (Fox Chase Cancer Center)
for PTP1B K/R construct, Sean Adams (UCD) for UCP1 antibodies, and
Yu-Hua Tseng (Joslin Diabetes Center/Harvard Medical School) for RT-
PCR primer sequences. Initial portions of this study were performed in the
laboratory of Dr. Benjamin Neel (BIDMC/Harvard Medical School) and
we thank him for his help and support. We thank members of the
laboratory for critical comments on the manuscript.
Author Contributions
Conceived and designed the experiments: FGH. Performed the experi-
ments: KM AB NN IM HK FGH. Analyzed the data: KM AB NN FGH.
Contributed reagents/materials/analysis tools: KM HK FGH. Wrote the
paper: AB NN FGH.
PTP1B and Brown Fat Differentiation
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e16446References
1. Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance
and glucose homeostasis. Nature 444: 847–853.
2. Farmer SR (2008) Molecular determinants of brown adipocyte formation and
function. Genes Dev 22: 1269–1275.
3. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and
physiological significance. Physiol Rev 84: 277–359.
4. Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak LP (1995) Expression
of the mitochondrial uncoupling protein gene from the aP2 gene promoter
prevents genetic obesity. J Clin Invest 96: 2914–2923.
5. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, et al. (2001)
FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia,
and diet-induced insulin resistance. Cell 106: 563–573.
6. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, et al.
(2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E-
BP1. Nat Med 7: 1128–1132.
7. Xue B, Rim JS, Hogan JC, Coulter AA, Koza RA, et al. (2007) Genetic
variability affects the development of brown adipocytes in white fat but not in
interscapular brown fat. J Lipid Res 48: 41–51.
8. Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, et al.
(2009) High incidence of metabolically active brown adipose tissue in healthy
adult humans: effects of cold exposure and adiposity. Diabetes 58: 1526–1531.
9. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, et al. (2009)
Identification and importance of brown adipose tissue in adult humans.
N Engl J Med 360: 1509–1517.
10. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, et al. (2009)
Functional brown adipose tissue in healthy adults. N Engl J Med 360:
1518–1525.
11. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM,
Kemerink GJ, et al. (2009) Cold-activated brown adipose tissue in healthy men.
N Engl J Med 360: 1500–1508.
12. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional
regulation of adipogenesis. Genes Dev 14: 1293–1307.
13. Rangwala SM, Lazar MA (2000) Transcriptional control of adipogenesis. Annu
Rev Nutr 20: 535–559.
14. Koutnikova H, Auwerx J (2001) Regulation of adipocyte differentiation. Ann
Med 33: 556–561.
15. Camp HS, Ren D, Leff T (2002) Adipogenesis and fat-cell function in obesity
and diabetes. Trends Mol Med 8: 442–447.
16. Kajimura S, Seale P, Spiegelman BM (2010) Transcriptional control of brown
fat development. Cell Metab 11: 257–262.
17. Farmer SR (2006) Transcriptional control of adipocyte formation. Cell Metab 4:
263–273.
18. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, et al. (2008) New
role of bone morphogenetic protein 7 in brown adipogenesis and energy
expenditure. Nature 454: 1000–1004.
19. Gregoire FM, Smas CM, Sul HS (1998) Understanding adipocyte differentia-
tion. Physiol Rev 78: 783–809.
20. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, et al. (2001)
Essential role of insulin receptor substrate 1 in differentiation of brown
adipocytes. Mol Cell Biol 21: 319–329.
21. Fasshauer M, Klein J, Ueki K, Kriauciunas KM, Benito M, et al. (2000)
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4
translocation and glucose uptake in brown adipocytes. J Biol Chem 275:
25494–25501.
22. Entingh AJ, Taniguchi CM, Kahn CR (2003) Bi-directional regulation of brown
fat adipogenesis by the insulin receptor. J Biol Chem 278: 33377–33383.
23. Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR (2004) Differential roles of
insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24:
1918–1929.
24. Sun H, Tonks NK (1994) The coordinated action of protein tyrosine
phosphatases and kinases in cell signaling. Trends Biochem Sci 19: 480–485.
25. Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to
disease. Nat Rev Mol Cell Biol 7: 833–846.
26. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG (1992) The
nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic
reticulum via its 35 amino acid C-terminal sequence. Cell 68: 545–560.
27. Woodford-Thomas TA, Rhodes JD, Dixon JE (1992) Expression of a protein
tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts.
J Cell Biol 117: 401–414.
28. Haj FG, Verveer PJ, Squire A, Neel BG, Bastiaens PI (2002) Imaging sites of
receptor dephosphorylation by PTP1B on the surface of the endoplasmic
reticulum. Science 295: 1708–1711.
29. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, et al. (1999)
Increased insulin sensitivity and obesity resistance in mice lacking the protein
tyrosine phosphatase-1B gene. Science 283: 1544–1548.
30. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, et al. (2000) Increased
energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in
protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20: 5479–5489.
31. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, et al. (2006)
Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med
12: 917–924.
32. Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, et al. (2007) Improved
glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine
phosphatase 1B. Mol Cell Biol 27: 7727–7734.
33. Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, et al. (2008) Liver-
Specific Deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) Improves
Metabolic Syndrome and Attenuates Diet-Induced ER Stress. Diabetes.
34. Xue B, Pulinilkunnil T, Murano I, Bence KK, He H, et al. (2009) Neuronal
protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic
AMPK and isoform-specific activation of AMPK in peripheral tissues. Mol Cell
Biol 29: 4563–4573.
35. Miranda S, Gonzalez-Rodriguez A, Revuelta-Cervantes J, Rondinone CM,
Valverde AM (2010) Beneficial effects of PTP1B deficiency on brown adipocyte
differentiation and protection against apoptosis induced by pro- and anti-
inflammatory stimuli. Cell Signal 22: 645–659.
36. Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG (2003) Regulation of
receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol
Chem 278: 739–744.
37. Flint AJ, Tiganis T, Barford D, Tonks NK (1997) Development of ‘‘substrate-
trapping’’ mutants to identify physiological substrates of protein tyrosine
phosphatases. Proc Natl Acad Sci U S A 94: 1680–1685.
38. Dadke S, Cotteret S, Yip SC, Jaffer ZM, Haj F, et al. (2007) Regulation of
protein tyrosine phosphatase 1B by sumoylation. Nat Cell Biol 9: 80–85.
39. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, et al. (2004) Transgenic
overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin
resistance, but overexpression with leukocyte antigen-related phosphatase does
not additively impair insulin action. J Biol Chem 279: 24844–24851.
40. Tseng YH, Butte AJ, Kokkotou E, Yechoor VK, Taniguchi CM, et al. (2005)
Prediction of preadipocyte differentiation by gene expression reveals role of
insulin receptor substrates and necdin. Nat Cell Biol 7: 601–611.
41. Sul HS (2009) Minireview: Pref-1: role in adipogenesis and mesenchymal cell
fate. Mol Endocrinol 23: 1717–1725.
42. Valverde AM, Kahn CR, Benito M (1999) Insulin signaling in insulin receptor
substrate (IRS)-1-deficient brown adipocytes: requirement of IRS-1 for lipid
synthesis. Diabetes 48: 2122–2131.
43. Goldstein BJ (2001) Protein-tyrosine phosphatase 1B (PTP1B): a novel
therapeutic target for type 2 diabetes mellitus, obesity and related states of
insulin resistance. Curr Drug Targets Immune Endocr Metabol Disord 1:
265–275.
44. Tonks NK (2003) PTP1B: from the sidelines to the front lines! FEBS Lett 546:
140–148.
45. Calera MR, Vallega G, Pilch PF (2000) Dynamics of protein-tyrosine
phosphatases in rat adipocytes. J Biol Chem 275: 6308–6312.
46. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M (2000) Tyrosine
dephosphorylation and deactivation of insulin receptor substrate-1 by protein-
tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary
complex with the Grb2 adaptor protein. J Biol Chem 275: 4283–4289.
47. Vila-Bedmar R, Lorenzo M, Fernandez-Veledo S (2010) Adenosine 59-
monophosphate-activated protein kinase-mammalian target of rapamycin cross
talk regulates brown adipocyte differentiation. Endocrinology 151: 980–992.
48. Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein
kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem
67: 821–855.
49. Winder WW, Hardie DG (1999) AMP-activated protein kinase, a metabolic
master switch: possible roles in type 2 diabetes. Am J Physiol 277: E1–10.
50. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al. (2003) Complexes
between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/
beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:
28.
51. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al. (2004) The
tumor suppressor LKB1 kinase directly activates AMP-activated kinase and
regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101:
3329–3335.
52. Venable CL, Frevert EU, Kim YB, Fischer BM, Kamatkar S, et al. (2000)
Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits
insulin-stimulated phosphoinositide 3-kinase activity without altering glucose
transport or Akt/Protein kinase B activation. J Biol Chem 275: 18318–18326.
53. Frevert EU, Bjorbaek C, Venable CL, Keller SR, Kahn BB (1998) Targeting of
constitutively active phosphoinositide 3-kinase to GLUT4-containing vesicles in
3T3-L1 adipocytes. J Biol Chem 273: 25480–25487.
54. Nave BT, Haigh RJ, Hayward AC, Siddle K, Shepherd PR (1996)
Compartment-specific regulation of phosphoinositide 3-kinase by platelet-
derived growth factor and insulin in 3T3-L1 adipocytes. Biochem J 318(Pt 1):
55–60.
55. Clark SF, Martin S, Carozzi AJ, Hill MM, James DE (1998) Intracellular
localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in
adipocytes: potential involvement of a membrane skeleton. J Cell Biol 140:
1211–1225.
56. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, et al. (2000) Inhibition
of adipogenesis by Wnt signaling. Science 289: 950–953.
57. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, et al. (2002) Regulation
of Wnt signaling during adipogenesis. J Biol Chem 277: 30998–31004.
PTP1B and Brown Fat Differentiation
PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e1644658. Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, et al. (2003) Peroxisome-
proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling
during adipogenesis. Biochem J 376: 607–613.
59. Xu G, Arregui C, Lilien J, Balsamo J (2002) PTP1B modulates the association of
beta-catenin with N-cadherin through binding to an adjacent and partially
overlapping target site. J Biol Chem 277: 49989–49997.
60. Xu G, Craig AW, Greer P, Miller M, Anastasiadis PZ, et al. (2004) Continuous
association of cadherin with beta-catenin requires the non-receptor tyrosine-
kinase Fer. J Cell Sci 117: 3207–3219.
61. Klein J, Fasshauer M, Ito M, Lowell BB, Benito M, et al. (1999) beta(3)-
adrenergic stimulation differentially inhibits insulin signaling and decreases
insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274:
34795–34802.
62. Moyers JS, Bilan PJ, Reynet C, Kahn CR (1996) Overexpression of Rad inhibits
glucose uptake in cultured muscle and fat cells. J Biol Chem 271: 23111–23116.
PTP1B and Brown Fat Differentiation
PLoS ONE | www.plosone.org 12 January 2011 | Volume 6 | Issue 1 | e16446